Agenus/LinkedIn
Jul 12, 2025, 17:14
Agenus Responds to New Regulatory Environment at FDA
Agenus posted on LinkedIn:
“This morning on CNBC’s Squawk Box, FDA Commissioner Dr. Marty Makary, underscored the agency’s renewed commitment to eliminating conflicts of interest and accelerating the approval of innovative, life-saving cancer treatments.
Upon learning about the Commissioner’s new National Priority Voucher Program, we immediately notified the FDA of our interest and began the application process.
Our mission to develop radiation and chemo-free therapies for GI cancers is only just beginning and we remain deeply focused on bringing hope to patients facing this devastating disease.”
More posts featuring Agenus.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 2, 2025, 06:54
Aug 2, 2025, 06:37
Aug 2, 2025, 00:00
Aug 1, 2025, 20:57
Aug 1, 2025, 20:38